![ACCELERATED BIOSCIENCES CORP](https://gocience.com/logos/new/8ebf1e8db0f27fe43ccaf42329cf96c4b06b4b07f613014f64dd9164289cb1e6.jpg)
Accelerated Biosciences Corp
Biotechnology, 1769 1st St, Philadelphia, Pennsylvania, 90266, United States, 1-10 Employees
Phone Number: 31********
Who is ACCELERATED BIOSCIENCES CORP
Accelerated Biosciences Corp. is commercializing human trophoblast stem cells isolated from the trophectoderm of embryos from women with ectopic pregnancies. hTSCs are ethically sourced a...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 1769 1st St, Philadelphia, Pennsylvania, 90266, United States
-
Date Founded: 2013
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
Does something look wrong? Fix it. | View contact records from ACCELERATED BIOSCIENCES CORP
ACCELERATED BIOSCIENCES CORP Org Chart and Mapping
Similar Companies to ACCELERATED BIOSCIENCES CORP
iCell Gene Therapeutics
-
11-50
-
$ Under 1 Million
Indapta Therapeutics
-
1-10
-
$ 250 Million to 500 Million
ONK Therapeutics
-
11-50
-
$ Under 1 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ACCELERATED BIOSCIENCES CORP
Answer: ACCELERATED BIOSCIENCES CORP's headquarters are located at 1769 1st St, Philadelphia, Pennsylvania, 90266, United States
Answer: ACCELERATED BIOSCIENCES CORP's phone number is 31********
Answer: ACCELERATED BIOSCIENCES CORP's official website is https://acceleratedbio.com
Answer: ACCELERATED BIOSCIENCES CORP's revenue is Under $1 Million
Answer: ACCELERATED BIOSCIENCES CORP has 1-10 employees
Answer: ACCELERATED BIOSCIENCES CORP is in Biotechnology
Answer: ACCELERATED BIOSCIENCES CORP top competitors include: iCell Gene Therapeutics , Indapta Therapeutics , ONK Therapeutics
Answer: ACCELERATED BIOSCIENCES CORP contact info: Phone number: 31******** Website: https://acceleratedbio.com
Answer: Accelerated Biosciences Corp. is commercializing human trophoblast stem cells isolated from the trophectoderm of embryos from women with ectopic pregnancies. hTSCs are ethically sourced and have immune-privileged characteristics. It is an abundant and dynamic pluripotent stem cell platform for basic research, disease modeling, toxicology, drug discovery, and cell therapy.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month